GLPG

Galapagos NV

Stock NASDAQ – Stock Market Prices, News & Analysis

Galapagos NV is a biotechnology company focused on the discovery and development of small molecules across various therapeutic areas.

$ 28.40
1.22 %

Galapagos NV

$ 28.40
1.22 %
GLPG

Galapagos NV is a biotechnology company focused on the discovery and development of small molecules across various therapeutic areas.

Price history of Galapagos NV
Price history of Galapagos NV

Performance & Momentum

6 Months 11.14 %
1 Year 7.21 %
3 Years 26.65 %
5 Years 63.48 %

Strategic Analysis

Galapagos NV • 2026

Galapagos NV positions itself as a specialized player in European biotechnology, focused on the discovery and development of innovative small molecules in various therapeutic areas. Its model is based on strong expertise in medical research and strategic partnerships to optimize its clinical pipelines.

Strengths
  • Recognized expertise in research and development of small molecules
  • Positioning in diversified therapeutic indications
  • Valuation potential linked to clinical advancements and collaborations
Weaknesses
  • Marked historical volatility with prolonged negative performance
  • Model dependent on clinical success and regulatory validation cycles
Momentum

The current momentum reflects a relative recovery after a prolonged period of underperformance, supported by positive outlooks related to recent clinical progress. This dynamic invites careful monitoring to capture potential recovery while remaining cautious of sector volatility.

Similar stocks to Galapagos NV

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone